Rifabutin: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Rifabutin. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Discolored urine | 30% |
| Rash | 11% |
| Nausea | 6% |
| Headache | 5% |
| Abdominal pain | 4% |
| Diarrhea | 3% |
| Dyspepsia | 3% |
| Eructation | 3% |
| Nausea and vomiting | 3% |
| Taste perversion | 3% |
| Fever | 2% |
| Pain | 2% |
| Anorexia | 2% |
| Flatulence | 2% |
| Myalgia | 2% |
| Asthenia | 1% |
| Chest pain | 1% |
| Vomiting | 1% |
| Insomnia | 1% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
MYCOBUTIN Capsules are indicated for the prevention of disseminated Mycobacterium avium complex (MAC) disease in patients with advanced HIV infection.
Source: FDA labeling via NIH DailyMed (set b8351a60…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.